Parkinson's Disease Neuroprotection Clinical Trial

Project Details

Description

DESCRIPTION (provided by applicant): This application, in response to a request from the Neurodegeneration and Clinical Trials Groups of the NINDS, provides data in support of our ability to become a clinical center to collaborate in the performance of a large, double-blind randomized trial of two or more potential neuroprotective agents in patients early in the course of Parkinson's disease. Our group has been conducting clinical trials in Parkinson's disease patients since 1983. We have a large patient population and a wide referral network. Administrative and coordinating systems necessary for the successful completion of such a trial are already in place and working. We have a record of adhering to similar common protocols and cooperating with other centers and will do so for this trial.
StatusFinished
Effective start/end date9/30/0211/30/15

Funding

  • National Institutes of Health: $47,759.00
  • National Institutes of Health: $5,508.00
  • National Institutes of Health: $46,752.00
  • National Institutes of Health: $41,138.00
  • National Institutes of Health: $13,948.00
  • National Institutes of Health: $31,100.00
  • National Institutes of Health: $31,100.00
  • National Institutes of Health: $20,453.00
  • National Institutes of Health: $57,470.00
  • National Institutes of Health: $47,416.00
  • National Institutes of Health: $20,043.00
  • National Institutes of Health: $41,985.00
  • National Institutes of Health: $113,555.00
  • National Institutes of Health: $113,555.00

ASJC

  • Medicine(all)
  • Neuroscience(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.